U.S. Genetic Disease Diagnostics Market Size & Outlook
Related Markets
U.S. genetic disease diagnostics market highlights
- The U.S. genetic disease diagnostics market generated a revenue of USD 4,298.7 million in 2024 and is expected to reach USD 19,326.6 million by 2033.
- The U.S. market is expected to grow at a CAGR of 17.9% from 2025 to 2033.
- In terms of segment, next generation sequencing was the largest revenue generating technology in 2024.
- Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
Genetic disease diagnostics market data book summary
| Market revenue in 2024 | USD 4,298.7 million |
| Market revenue in 2033 | USD 19,326.6 million |
| Growth rate | 17.9% (CAGR from 2025 to 2033) |
| Largest segment | Next generation sequencing |
| Fastest growing segment | Next Generation Sequencing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Next Generation Sequencing, Array Technology, PCR - based Testing, FISH |
| Key market players worldwide | Abbott, Celera Motion, ElitechGroup, PerkinElmer, Quest Diagnostics Inc, AutoGenomics, Roche Diagnostics, Biorad Medisys, Transgenomic |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.7% of the global genetic disease diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. genetic disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 19,326.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genetic Disease Diagnostics Market Scope
Genetic Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Transgenomic | View profile | 101-250 | Omaha, Nebraska, United States, North America | http://www.transgenomic.com |
| Biorad Medisys | View profile | 501-1000 | Pune, Maharashtra, India, Asia | https://bioradmedisys.com/ |
| AutoGenomics | View profile | 51-100 | Vista, California, United States, North America | http://www.autogenomics.com |
| Roche Diagnostics | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Celera Motion | View profile | 101-250 | Bedford, Massachusetts, United States, North America | https://www.celeramotion.com/ |
| ElitechGroup | View profile | 11-50 | https://www.elitechgroup.co.za/ | |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
U.S. genetic disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genetic disease diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 60.36% in 2024. Horizon Databook has segmented the U.S. genetic disease diagnostics market based on next generation sequencing, array technology, pcr - based testing, fish covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. genetic disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. genetic disease diagnostics market databook
-
Our clientele includes a mix of genetic disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. genetic disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. genetic disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. genetic disease diagnostics market size, by technology, 2021-2033 (US$M)
U.S. Genetic Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
